Early Postoperative Monitoring of the Liver Graft

Liver transplantation (LT) is a common current technique for end-stage liver disease. Complications after the surgical procedure, though uncommon, can be of very different origin and can also be severe enough to lead to liver and multiorgan failure and finally graft loss and/or recipient’s death. Intensivists and the surgical team must be familiarized with these early complications to detect them as soon as possible in order to use the best diagnostic tools and take the best therapeutic measures to restore anatomical integrity and organ function to optimize the liver graft. In this chapter, we present an updated state of the art for efficiently tackling with all different, most usual complications that an LT patient can present during early postoperative period

Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study

Background: Limited evidence exists on the role of glucose-lowering drugs in patients with COVID-19. Our main objective was to examine the association between in-hospital death and each routine at-home glucose-lowering drug both individually and in combination with metformin in patients with type 2 diabetes mellitus admitted for COVID-19. We also evaluated their association with the composite outcome of the need for ICU admission, invasive and non-invasive mechanical ventilation, or in-hospital death as well as on the development of in-hospital complications and a long-time hospital stay. Methods: We selected all patients with type 2 diabetes mellitus in the Spanish Society of Internal Medicine's registry of COVID-19 patients (SEMI-COVID-19 Registry). It is an ongoing, observational, multicenter, nationwide cohort of patients admitted for COVID-19 in Spain from March 1, 2020. Each glucose-lowering drug user was matched with a user of other glucose-lowering drugs in a 1:1 manner by propensity scores. In order to assess the adequacy of propensity score matching, we used the standardized mean difference found in patient characteristics after matching. There was considered to be a significant imbalance in the group if a standardized mean difference > 10% was found. To evaluate the association between treatment and study outcomes, both conditional logit and mixed effect logistic regressions were used when the sample size was ≥ 100. Results: A total of 2666 patients were found in the SEMI-COVID-19 Registry, 1297 on glucose-lowering drugs in monotherapy and 465 in combination with metformin. After propensity matching, 249 patients on metformin, 105 on dipeptidyl peptidase-4 inhibitors, 129 on insulin, 127 on metformin/dipeptidyl peptidase-4 inhibitors, 34 on metformin/sodium-glucose cotransporter 2 inhibitor, and 67 on metformin/insulin were selected. No at-home glucose-lowering drugs showed a significant association with in-hospital death; the composite outcome of the need of intensive care unit admission, mechanical ventilation, or in-hospital death; in-hospital complications; or long-time hospital stays. Conclusions: In patients with type 2 diabetes mellitus admitted for COVID-19, at-home glucose-lowering drugs showed no significant association with mortality and adverse outcomes. Given the close relationship between diabetes and COVID-19 and the limited evidence on the role of glucose-lowering drugs, prospective studies are needed

Productivity trends and collaboration patterns: A diachronic study in the eating disorders field

[EN] Objective The present study seeks to extend previous bibliometric studies on eating disorders (EDs) by including a time-dependent analysis of the growth and evolution of multi-author collaborations and their correlation with ED publication trends from 1980 to 2014 (35 years). Methods Using standardized practices, we searched Web of Science (WoS) Core Collection (WoSCC) (indexes: Science Citation Index-Expanded [SCIE], & Social Science Citation Index [SSCI]) and Scopus (areas: Health Sciences, Life Sciences, & Social Sciences and Humanities) to identify a large sample of articles related to EDs. We then submitted our sample of articles to bibliometric and graph theory analyses to identify co-authorship and social network patterns. Results We present a large number of detailed findings, including a clear pattern of scientific growth measured as number of publications per five-year period or quinquennium (Q), a tremendous increase in the number of authors attracted by the ED subject, and a very high and steady growth in collaborative work. Conclusions We inferred that the noted publication growth was likely driven by the noted increase in the number of new authors per Q. Social network analyses suggested that collaborations within ED follow patters of interaction that are similar to well established and recognized disciplines, as indicated by the presence of a ¿giant cluster¿, high cluster density, and the replication of the ¿small world¿ phenomenon¿the principle that we are all linked by short chains of acquaintances.This work was performed with a subsidy from Universidad Catolica de Valencia "San Vicente Martir" to resarch group INDOTEI: Evaluacion de la Ciencia, for the years 2016-2017. This work is benefited from Spanish Government assistance through Government Delegation for the National Drugs Plan of the Ministry of Health, Social Services and Equality (project 2016/028); and National R+D+I (projects: CS02012-39632-C02-01 and CS02015-65594-C2-2-R) and 2015-Networks of Excellence Call (project CS02015-71867-REDT) of the Ministry of Economy and Competitiveness.Valderrama Zurian, JC.; Aguilar-Moya, R.; Cepeda-Benito, A.; Melero-Fuentes, D.; Navarro-Moreno, MÁ.; Gandía-Balaguer, A.; Aleixandre-Benavent, R. (2017). Productivity trends and collaboration patterns: A diachronic study in the eating disorders field. PLoS ONE. 12(8):1-17. https://doi.org/10.1371/journal.pone.0182760S117128McClelland, J., Bozhilova, N., Campbell, I., & Schmidt, U. (2013). A Systematic Review of the Effects of Neuromodulation on Eating and Body Weight: Evidence from Human and Animal Studies. European Eating Disorders Review, 21(6), 436-455. doi:10.1002/erv.2256Lancelot, C., Brooks-Gunn, J., Warren, M. P., & Newman, D. L. (1991). Comparison of DSM-III and DSM-III-R bulimia nervosa classifications for psychopathology and other eating behaviors. International Journal of Eating Disorders, 10(1), 57-66. doi:10.1002/1098-108x(199101)10:13.0.co;2-tWONDERLICH, S. A., CROSBY, R. D., JOINER, T., PETERSON, C. B., BARDONE-CONE, A., KLEIN, M., … VRSHEK, S. (2005). Personality subtyping and bulimia nervosa: psychopathological and genetic correlates. Psychological Medicine, 35(5), 649-657. doi:10.1017/s0033291704004234Spitzer, R. L., Devlin, M. J., Walsh, B. T., Hasin, D., Wing, R., Marcus, M. D., … Nonas, C. (1991). Binge eating disorder: To be or not to be in DSM-IV. International Journal of Eating Disorders, 10(6), 627-629. doi:10.1002/1098-108x(199111)10:63.0.co;2-4Wonderlich, S. A., Gordon, K. H., Mitchell, J. E., Crosby, R. D., & Engel, S. G. (2014). The Validity and Clinical Utility of Binge Eating Disorder. FOCUS, 12(4), 489-505. doi:10.1176/appi.focus.120412Theander, S. S. (2002). Literature on eating disorders during 40 Years: increasing number of papers, emergence of bulimia nervosa. European Eating Disorders Review, 10(6), 386-398. doi:10.1002/erv.495Clinton, D. (2010). Towards an ecology of eating disorders: Creating sustainability through the integration of scientific research and clinical practice. European Eating Disorders Review, 18(1), 1-9. doi:10.1002/erv.986Soh, N. L.-W., & Walter, G. (2013). Publications on cross-cultural aspects of eating disorders. Journal of Eating Disorders, 1(1). doi:10.1186/2050-2974-1-4Wuchty, S., Jones, B. F., & Uzzi, B. (2007). The Increasing Dominance of Teams in Production of Knowledge. Science, 316(5827), 1036-1039. doi:10.1126/science.1136099Kumar, S. (2015). Co-authorship networks: a review of the literature. Aslib Journal of Information Management, 67(1), 55-73. doi:10.1108/ajim-09-2014-0116Barabási, A. ., Jeong, H., Néda, Z., Ravasz, E., Schubert, A., & Vicsek, T. (2002). Evolution of the social network of scientific collaborations. Physica A: Statistical Mechanics and its Applications, 311(3-4), 590-614. doi:10.1016/s0378-4371(02)00736-7Newman, M. E. J. (2004). Coauthorship networks and patterns of scientific collaboration. Proceedings of the National Academy of Sciences, 101(Supplement 1), 5200-5205. doi:10.1073/pnas.0307545100Aleixandre-Benavent, R., & Alonso-Arroyo, A. (2011). Indicadores bibliométricos, patología del aparato respiratorio y reducción del consumo de tabaco. Revista de Patología Respiratoria, 14(1), 1-3. doi:10.1016/s1576-9895(11)70095-9Pino-Díaz, J., Jiménez-Contreras, E., Ruíz-Baños, R., & Bailón-Moreno, R. (2011). Evaluación de redes tecnocientíficas: la red española sobre Áreas Protegidas, según la Web of Science. Revista española de Documentación Científica, 34(3), 301-333. doi:10.3989/redc.2011.3.804Valderrama-Zurián, J.-C., Aguilar-Moya, R., Melero-Fuentes, D., & Aleixandre-Benavent, R. (2015). A systematic analysis of duplicate records in Scopus. Journal of Informetrics, 9(3), 570-576. doi:10.1016/j.joi.2015.05.002Guardiola-Wanden-Berghe, R., Sanz-Valero, J., & Wanden-Berghe, C. (2012). Medical subject headings versus American Psychological Association Index Terms: indexing eating disorders. Scientometrics, 94(1), 305-311. doi:10.1007/s11192-012-0866-7Soh, N., Walter, G., Touyz, S., Russell, J., Malhi, G. S., & Hunt, G. E. (2012). Food for thought: Comparison of citations received from articles appearing in specialized eating disorder journals versus general psychiatry journals. International Journal of Eating Disorders, 45(8), 990-994. doi:10.1002/eat.22036Theander, S. S. (2004). Trends in the literature on eating disorders over 36 years(1965-2000): terminology, interpretation and treatment. European Eating Disorders Review, 12(1), 4-17. doi:10.1002/erv.559Kawamura, M., Thomas, C. D. L., Tsurumoto, A., Sasahara, H., & Kawaguchi, Y. (2000). Lotka’s law and productivity index of authors in a scientific journal. Journal of Oral Science, 42(2), 75-78. doi:10.2334/josnusd.42.75Lawani SM. Quality, collaboration and citations in cancer research: A bibliometric study. PhD thesis. Florida State University, Tallahassee. 1980.Watts, D. J., & Strogatz, S. H. (1998). Collective dynamics of ‘small-world’ networks. Nature, 393(6684), 440-442. doi:10.1038/30918Jacomy, M., Venturini, T., Heymann, S., & Bastian, M. (2014). ForceAtlas2, a Continuous Graph Layout Algorithm for Handy Network Visualization Designed for the Gephi Software. PLoS ONE, 9(6), e98679. doi:10.1371/journal.pone.0098679Pike, K. M., & Dunne, P. E. (2015). The rise of eating disorders in Asia: a review. Journal of Eating Disorders, 3(1). doi:10.1186/s40337-015-0070-2El Ghoch, M., Soave, F., Calugi, S., & Dalle Grave, R. (2013). Eating Disorders, Physical Fitness and Sport Performance: A Systematic Review. Nutrients, 5(12), 5140-5160. doi:10.3390/nu5125140Jones, A. W. (2007). The distribution of forensic journals, reflections on authorship practices, peer-review and role of the impact factor. Forensic Science International, 165(2-3), 115-128. doi:10.1016/j.forsciint.2006.05.013Baker, T., Hatsukami, D., Lerman, C., O’Malley, S., Shields, A., & Fiore, M. (2003). Transdisciplinary science applied to the evaluation of treatments for tobacco use. Nicotine & Tobacco Research, 5(6), 89-99. doi:10.1080/14622200310001625564González-Alcaide, G., Melero-Fuentes, D., Aleixandre-Benavent, R., & Valderrama-Zurián, J.-C. (2013). Productivity and Collaboration in Scientific Publications on Criminology. Journal of Criminal Justice Education, 24(1), 15-37. doi:10.1080/10511253.2012.664153López-Muñoz, F., Alamo, C., Rubio, G., García-García, P., Martín-Agueda, B., & Cuenca, E. (2003). Bibliometric analysis of biomedical publications on SSRI during 1980-2000. Depression and Anxiety, 18(2), 95-103. doi:10.1002/da.10121González-Alcaide, G., Aleixandre-Benavent, R., Navarro-Molina, C., & Valderrama-Zurián, J. C. (2008). Coauthorship networks and institutional collaboration patterns in reproductive biology. Fertility and Sterility, 90(4), 941-956. doi:10.1016/j.fertnstert.2007.07.1378González-Alcaide, G., Park, J., Huamaní, C., Belinchón, I., & Ramos, J. M. (2015). Evolution of Cooperation Patterns in Psoriasis Research: Co-Authorship Network Analysis of Papers in Medline (1942–2013). PLOS ONE, 10(12), e0144837. doi:10.1371/journal.pone.0144837Bordons, M., & Ángeles Zulueta, M. (2002). La interdisciplinariedad en los grupos españoles de investigación en el área cardiovascular. Revista Española de Cardiología, 55(9), 900-912. doi:10.1016/s0300-8932(02)76728-6Chan, H. F., Önder, A. S., & Torgler, B. (2015). The first cut is the deepest: repeated interactions of coauthorship and academic productivity in Nobel laureate teams. Scientometrics, 106(2), 509-524. doi:10.1007/s11192-015-1796-yBordons, M., Aparicio, J., González-Albo, B., & Díaz-Faes, A. A. (2015). The relationship between the research performance of scientists and their position in co-authorship networks in three fields. Journal of Informetrics, 9(1), 135-144. doi:10.1016/j.joi.2014.12.001Newman, M. E. J. (2001). The structure of scientific collaboration networks. Proceedings of the National Academy of Sciences, 98(2), 404-409. doi:10.1073/pnas.98.2.404Fatt, C. K., Ujum, E. A., & Ratnavelu, K. (2010). The structure of collaboration in the Journal of Finance. Scientometrics, 85(3), 849-860. doi:10.1007/s11192-010-0254-0Kretschmer, H. (2004). Author productivity and geodesic distance in bibliographic co-authorship networks, and visibility on the Web. Scientometrics, 60(3), 409-420. doi:10.1023/b:scie.0000034383.86665.22Yan, E., Ding, Y., & Zhu, Q. (2009). Mapping library and information science in China: a coauthorship network analysis. Scientometrics, 83(1), 115-131. doi:10.1007/s11192-009-0027-9Yin, L., Kretschmer, H., Hanneman, R. A., & Liu, Z. (2006). Connection and stratification in research collaboration: An analysis of the COLLNET network. Information Processing & Management, 42(6), 1599-1613. doi:10.1016/j.ipm.2006.03.021Lambiotte, R., & Panzarasa, P. (2009). Communities, knowledge creation, and information diffusion. Journal of Informetrics, 3(3), 180-190. doi:10.1016/j.joi.2009.03.007Leydesdorff, L. (2012). World shares of publications of the USA, EU-27, and China compared and predicted using the new Web of Science interface versus Scopus. El Profesional de la Informacion, 21(1), 43-49. doi:10.3145/epi.2012.ene.06Bartol, T., Budimir, G., Dekleva-Smrekar, D., Pusnik, M., & Juznic, P. (2013). Assessment of research fields in Scopus and Web of Science in the view of national research evaluation in Slovenia. Scientometrics, 98(2), 1491-1504. doi:10.1007/s11192-013-1148-8López-Illescas, C., de Moya-Anegón, F., & Moed, H. F. (2008). Coverage and citation impact of oncological journals in the Web of Science and Scopus. Journal of Informetrics, 2(4), 304-316. doi:10.1016/j.joi.2008.08.001Warren, C. S., Gleaves, D. H., Cepeda-Benito, A., Fernandez, M. del C., & Rodriguez-Ruiz, S. (2005). Ethnicity as a protective factor against internalization of a thin ideal and body dissatisfaction. International Journal of Eating Disorders, 37(3), 241-249. doi:10.1002/eat.20102Prince, R., & Thebaud, E. F. (1983). Is Anorexia Nervosa a Culture-Bound Syndrome? Transcultural Psychiatric Research Review, 20(4), 299-302. doi:10.1177/136346158302000419Miller, M. N., & Pumariega, A. J. (2001). Culture and Eating Disorders: A Historical and Cross-Cultural Review. Psychiatry: Interpersonal and Biological Processes, 64(2), 93-110. doi:10.1521/psyc.64.2.93.1862

Clonal chromosomal mosaicism and loss of chromosome Y in elderly men increase vulnerability for SARS-CoV-2

The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID-19) had an estimated overall case fatality ratio of 1.38% (pre-vaccination), being 53% higher in males and increasing exponentially with age. Among 9578 individuals diagnosed with COVID-19 in the SCOURGE study, we found 133 cases (1.42%) with detectable clonal mosaicism for chromosome alterations (mCA) and 226 males (5.08%) with acquired loss of chromosome Y (LOY). Individuals with clonal mosaic events (mCA and/or LOY) showed a 54% increase in the risk of COVID-19 lethality. LOY is associated with transcriptomic biomarkers of immune dysfunction, pro-coagulation activity and cardiovascular risk. Interferon-induced genes involved in the initial immune response to SARS-CoV-2 are also down-regulated in LOY. Thus, mCA and LOY underlie at least part of the sex-biased severity and mortality of COVID-19 in aging patients. Given its potential therapeutic and prognostic relevance, evaluation of clonal mosaicism should be implemented as biomarker of COVID-19 severity in elderly people. Among 9578 individuals diagnosed with COVID-19 in the SCOURGE study, individuals with clonal mosaic events (clonal mosaicism for chromosome alterations and/or loss of chromosome Y) showed an increased risk of COVID-19 lethality

DNA multigene characterization of Fasciola hepatica and Lymnaea neotropica and its fascioliasis transmission capacity in Uruguay, with historical correlation, human report review and infection risk analysis

Fascioliasis is a highly pathogenic zoonotic disease emerging in recent decades, in part due to the effects of climate and global changes. South America is the continent presenting more numerous human fascioliasis endemic areas and the highest Fasciola hepatica infection prevalences and intensities known in humans. These serious public health scenarios appear mainly linked to altitude areas in Andean countries, whereas lowland areas of non-Andean countries, such as Uruguay, only show sporadic human cases or outbreaks. To understand this difference, we characterized F. hepatica from cattle and horses and lymnaeids of Uruguay by sequencing of ribosomal DNA ITS-2 and ITS-1 spacers and mitochondrial DNA cox1, nad1 and 16S genes. Results indicate that vectors belong to Lymnaea neotropica instead of to Lymnaea viator, as always reported from Uruguay. Our correlation of fasciolid and lymnaeid haplotypes with historical data on the introduction and spread of livestock species into Uruguay allow to understand the molecular diversity detected. We study the life cycle and transmission features of F. hepatica by L. neotropica of Uruguay under standardized experimental conditions to enable a comparison with the transmission capacity of F. hepatica by Galba truncatula at very high altitude in Bolivia. Results demonstrate that although L. neotropica is a highly efficient vector in the lowlands, its transmission capacity is markedly lower than that of G. truncatula in the highlands. On this baseline, we review the human fascioliasis cases reported in Uruguay and analyze the present and future risk of human infection in front of future climate change estimations

Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children

We found that 19 (10.4%) of 183 unvaccinated children hospitalized for COVID-19 pneumonia had autoantibodies (auto-Abs) neutralizing type I IFNs (IFN-alpha 2 in 10 patients: IFN-alpha 2 only in three, IFN-alpha 2 plus IFN-omega in five, and IFN-alpha 2, IFN-omega plus IFN-beta in two; IFN-omega only in nine patients). Seven children (3.8%) had Abs neutralizing at least 10 ng/ml of one IFN, whereas the other 12 (6.6%) had Abs neutralizing only 100 pg/ml. The auto-Abs neutralized both unglycosylated and glycosylated IFNs. We also detected auto-Abs neutralizing 100 pg/ml IFN-alpha 2 in 4 of 2,267 uninfected children (0.2%) and auto-Abs neutralizing IFN-omega in 45 children (2%). The odds ratios (ORs) for life-threatening COVID-19 pneumonia were, therefore, higher for auto-Abs neutralizing IFN-alpha 2 only (OR [95% CI] = 67.6 [5.7-9,196.6]) than for auto-Abs neutralizing IFN-. only (OR [95% CI] = 2.6 [1.2-5.3]). ORs were also higher for auto-Abs neutralizing high concentrations (OR [95% CI] = 12.9 [4.6-35.9]) than for those neutralizing low concentrations (OR [95% CI] = 5.5 [3.1-9.6]) of IFN-omega and/or IFN-alpha 2

Genetic landscape of 6089 inherited retinal dystrophies affected cases in Spain and their therapeutic and extended epidemiological implications

Inherited retinal diseases (IRDs), defined by dysfunction or progressive loss of photoreceptors, are disorders characterized by elevated heterogeneity, both at the clinical and genetic levels. Our main goal was to address the genetic landscape of IRD in the largest cohort of Spanish patients reported to date. A retrospective hospital-based cross-sectional study was carried out on 6089 IRD affected individuals (from 4403 unrelated families), referred for genetic testing from all the Spanish autonomous communities. Clinical, demographic and familiar data were collected from each patient, including family pedigree, age of appearance of visual symptoms, presence of any systemic findings and geographical origin. Genetic studies were performed to the 3951 families with available DNA using different molecular techniques. Overall, 53.2% (2100/3951) of the studied families were genetically characterized, and 1549 different likely causative variants in 142 genes were identified. The most common phenotype encountered is retinitis pigmentosa (RP) (55.6% of families, 2447/4403). The most recurrently mutated genes were PRPH2, ABCA4 and RS1 in autosomal dominant (AD), autosomal recessive (AR) and X-linked (XL) NON-RP cases, respectively; RHO, USH2A and RPGR in AD, AR and XL for non-syndromic RP; and USH2A and MYO7A in syndromic IRD. Pathogenic variants c.3386G > T (p.Arg1129Leu) in ABCA4 and c.2276G > T (p.Cys759Phe) in USH2A were the most frequent variants identified. Our study provides the general landscape for IRD in Spain, reporting the largest cohort ever presented. Our results have important implications for genetic diagnosis, counselling and new therapeutic strategies to both the Spanish population and other related populations.This work was supported by the Instituto de Salud Carlos III (ISCIII) of the Spanish Ministry of Health (FIS; PI16/00425 and PI19/00321), Centro de Investigación Biomédica en Red Enfermedades Raras (CIBERER, 06/07/0036), IIS-FJD BioBank (PT13/0010/0012), Comunidad de Madrid (CAM, RAREGenomics Project, B2017/BMD-3721), European Regional Development Fund (FEDER), the Organización Nacional de Ciegos Españoles (ONCE), Fundación Ramón Areces, Fundación Conchita Rábago and the University Chair UAM-IIS-FJD of Genomic Medicine. Irene Perea-Romero is supported by a PhD fellowship from the predoctoral Program from ISCIII (FI17/00192). Ionut F. Iancu is supported by a grant from the Comunidad de Madrid (CAM, PEJ-2017-AI/BMD7256). Marta del Pozo-Valero is supported by a PhD grant from the Fundación Conchita Rábago. Berta Almoguera is supported by a Juan Rodes program from ISCIII (JR17/00020). Pablo Minguez is supported by a Miguel Servet program from ISCIII (CP16/00116). Marta Corton is supported by a Miguel Servet program from ISCIII (CPII17/00006). The funders played no role in study design, data collection, data analysis, manuscript preparation and/or publication decisions